70.87 USD
+0.99 (+1.42%)
71.5 USD
+0.63 (+0.89%)
ChartMill assigns a Buy % Consensus number of 87% to RVMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 81.28. This target is 14.69% above the current price.
RVMD was analyzed by 26 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about RVMD.
In the previous month the buy percentage consensus was at a similar level.
RVMD was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Wolfe Research | Initiate | Outperform |
| 2025-11-06 | Needham | Maintains | Buy -> Buy |
| 2025-11-06 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-03 | RBC Capital | Initiate | Outperform |
| 2025-10-21 | Mizuho | Initiate | Outperform |
| 2025-10-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-10-17 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-10-16 | Stifel | Reiterate | Buy |
| 2025-09-12 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-09-11 | Needham | Maintains | Buy -> Buy |
| 2025-09-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-05 | Truist Securities | Initiate | Buy |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-08-18 | LifeSci Capital | Initiate | Outperform |
| 2025-08-15 | Wells Fargo | Initiate | Overweight |
| 2025-08-07 | Needham | Maintains | Buy -> Buy |
| 2025-07-15 | Goldman Sachs | Initiate | Buy |
| 2025-06-25 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-24 | Needham | Reiterate | Buy -> Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-08 | Needham | Reiterate | Buy -> Buy |
| 2025-05-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-28 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-01 | Stifel | Maintains | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
REVOLUTION MEDICINES INC / RVMD FAQ
What is the average price target for REVOLUTION MEDICINES INC (RVMD) stock?
26 analysts have analysed RVMD and the average price target is 81.28 USD. This implies a price increase of 14.69% is expected in the next year compared to the current price of 70.87.
How do analysts rate REVOLUTION MEDICINES INC (RVMD)?
The consensus rating for REVOLUTION MEDICINES INC (RVMD) is 86.9231 / 100 . This indicates that analysts generally have a positive outlook on the stock.